Our Bureau
Chennai
Recently, a new version of Tamil movie star Dhanush’s iconic film Raanjhanaa was re-released and has made headlines. The movie’s Tamil version, Ambikapathy, which was re-released last week had an AI-edited ending, completely different from how the film originally ended. Dhanush expressed his distress seeing his work changed by AI which was objected to by him but Eros International Media Limited has refuted his claims.
Dhanush recently put up a statement on X stating that AI-altered ending has disturbed him as it has completely erased the soul of the movie and it is now nothing like the film he did 12 years back. He highlighted that he had objected to any such changes and is deeply concerned by the usage of AI to alter art.
“The re-release of Raanjhanaa with an AI-altered climax has completely disturbed me. This alternate ending has stripped the film of its very soul, and the concerned parties went ahead with it despite my clear objection. This is not the film I committed to 12 years ago,” he wrote on X on Sunday night.
The actor further said, “The use of AI to alter films or content is a deeply concerning precedent for both art and artists. It threatens the integrity of storytelling and the legacy of cinema. I sincerely hope that stricter regulations are put in place to prevent such practices in the future.”
Eros International on the other hand issued a statement this Monday, on August 4th, claiming that they did contact the actor regarding the changes. They emphasised at that point of time there was no formal objection communicated to them before the re-release of Ambikapathy.
Eros International said, “We have always valued the contributions of every artist and creative partner associated with Raanjhanaa and Ambikapathy, including Mr Dhanush, lead actor, whose wonderful performance brought Kundan to life in an unforgettable way. We would like to respectfully clarify that an Eros representative had engaged in direct communication with Mr Dhanush’s team regarding the proposed revisions, and no formal objection was communicated to us prior to the AI-enhanced re-release of Ambikapathy.”
